Concepedia

Liviawati S. Wu

LS

Statistics

Publications

7

Citations

306

H-Index

7

Active since

2015

Affiliations

Janssen (Belgium)(Current)

Amgen (United States)

Janssen (United States)

Memorial Sloan Kettering Cancer Center

Vrije Universiteit Amsterdam

Liviawati S. Wu is an author at Janssen (Belgium) specializing in pharmacy, pharmacology, and multiple myeloma therapy.

Publications per year

2015–2024

7

Publications

7

Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects

Thuy Vu, Peiming Ma, Jiyun Sunny Chen et al. · Pharmaceutical Research · 2017 · 96 citations · Full text

, , +17

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

Diana Cortés‐Selva, Tatiana Perova, Sheri Skerget et al. · Blood · 2024 · 53 citations · Full text

, , +17

Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Correlative Analyses from MajesTEC-1

Diana Cortés‐Selva, Tineke Casneuf, Deeksha Vishwamitra et al. · Blood · 2022 · 46 citations

, , +17

Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1

Xin Miao, Liviawati S. Wu, Shun Xin Wang Lin et al. · Targeted Oncology · 2023 · 44 citations · Full text

, , +17

Population Pharmacokinetic Modeling of Plasma and Intracellular Ribavirin Concentrations in Patients with Chronic Hepatitis C Virus Infection

Liviawati S. Wu, Joseph E. Rower, James R. Burton et al. · Antimicrobial Agents and Chemotherapy · 2015 · 33 citations · Full text

, , +17

1–5 of 7